What sector does Beam Therapeutics Inc (BEAM) operate in?
Beam Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Beam Therapeutics Inc (BEAM) current stock price?
As of the latest data, Beam Therapeutics Inc stock price is $28.15, with a previous close of $26.93. Beam Therapeutics Inc gained $1.22 in the last trading session, representing a 4.51% increase.
What is Beam Therapeutics Inc (BEAM) current market capitalization?
Beam Therapeutics Inc market cap is approximately 2.86 billion.
What is Beam Therapeutics Inc (BEAM) Earnings Per Share (EPS)?
The trailing EPS is -$4.41, and the forward EPS is -$4.61.
What is Beam Therapeutics Inc (BEAM) EBITDA?
Beam Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -107.17 million.
Does Beam Therapeutics Inc (BEAM) pay dividends?
No. Beam Therapeutics Inc does not pay a dividend.
How did Beam Therapeutics Inc (BEAM) perform in its most recent earnings report?
In the last report (September 30, 2025), Beam Therapeutics Inc posted an EPS surprise of -4.76% and a revenue surprise of -23.79%.
When is Beam Therapeutics Inc (BEAM) next earnings report?
Beam Therapeutics Inc is expected to release its next earnings report on December 31, 2025.
What is Beam Therapeutics Inc (BEAM) beta (volatility) score?
Beam Therapeutics Inc has a beta of 2.073, indicating very high volatility compared to the market.